Envista is a medical instruments & supplies business based in the US. Envista shares (NVST) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $20.26 – an increase of 0.9% over the previous week. Envista employs 12,800 staff and has a trailing 12-month revenue of around $2.5 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $20.26 |
|---|---|
| 52-week range | $15.15 - $25.64 |
| 50-day moving average | $19.09 |
| 200-day moving average | $19.12 |
| Wall St. target price | $21.55 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-7.72 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $20.61 from 2024-11-18
| 1 week (2024-11-13) | 1.33% |
|---|---|
| 1 month (2024-10-18) | 9.16% |
| 3 months (2024-08-20) | 15.79% |
| 6 months (2024-05-20) | 12.81% |
| 1 year (2023-11-20) | -13.37% |
|---|---|
| 2 years (2022-11-18) | -44.01% |
| 3 years (2021-11-19) | 42.1 |
| 5 years (2019-11-20) | 27.63 |
Valuing Envista stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Envista's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Envista's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $293.4 million.
The EBITDA is a measure of a Envista's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.5 billion |
|---|---|
| Operating margin TTM | 3.74% |
| Gross profit TTM | $1.5 billion |
| Return on assets TTM | 1.69% |
| Return on equity TTM | -36.31% |
| Profit margin | -53.42% |
| Book value | $17.86 |
| Market Capitalization | $3.5 billion |
TTM: trailing 12 months
We're not expecting Envista to pay a dividend over the next 12 months.
Over the last 12 months, Envista's shares have ranged in value from as little as $15.145 up to $25.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Envista's is 1.308. This would suggest that Envista's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.